On Wednesday, Following Stocks were among the “Top Losers” of U.S. Stock Market: Vantage Drilling Company, (NYSEMKT:VTG), Western Asset Mortgage Capital, (NYSE:WMC), Paragon Offshore, (NYSE:PGN), Intrexon Corporation, (NYSE:XON)
Vantage Drilling Company, (NYSEMKT:VTG), with shares declined -4.73%, closed at $0.31.
Western Asset Mortgage Capital, (NYSE:WMC), with shares dropped -0.21%, settled at $14.38.
Paragon Offshore, (NYSE:PGN), with shares dipped -4.62%, and closed at $1.24.
Intrexon Corporation, (NYSE:XON), plummeted -4.61%, and closed at $43.28.
Latest NEWS regarding these Stocks are depicted underneath:
Vantage Drilling Company (NYSEMKT:VTG)
Vantage Drilling Company (VTG), has the beta value of 1.47, and its volatility for the week is 10.63%, while for the month it is 8.47%. The company has the market capitalization of $96.80M. The company holds the book value per share of 1.81, whereas cash per share is 0.27. Price to book ratio remained 0.17, while price to sale ratio is 0.11. Analysts mean recommendation for the stock is said to be 2.80 (where 1=Buy, 5=sale).
Vantage Drilling Corporation, through its auxiliaries, provides offshore contract drilling services in the United States and internationally. It offers drilling units, related equipment, and work crews under contract to drill oil and natural gas wells.
Western Asset Mortgage Capital Corporation (NYSE:WMC)
Western Asset Mortgage Capital Corporation (WMC), declared that its Board of Directors has declared a cash dividend of $0.67 per share for the first quarter of 2015. Recent dividend is payable on April 28, 2015 to ordinary shareholders of record as of April 6, 2015, with an ex-dividend date of April 1, 2015.
The Corporation also declared its estimated book value per share, as of February 28, 2015 was about $15.13. The February 28, 2015 book value is unaudited and is only an estimate which has not been verified or reviewed by any third party and is subject to normal quarterly reconciliation and other procedures. Further, the estimated book value is as of February 28, 2015 and does not comprise the dividend declared recently. Book value will fluctuate with market conditions, the results of the Corporation’s operations and other factors. The Corporation’s current book value may be materially different from the February 28, 2015 estimated book value.
Western Asset Mortgage Capital Corporation operates as a real estate investment trust in the United States. It primarily focuses on investing in, financing, and managing agency and non-agency residential mortgage-backed securities and commercial mortgage-backed securities.
Paragon Offshore plc (NYSE:PGN)
Paragon Offshore plc (PGN), has the market capitalization of $106.09M. On the other hand the stock’s volatility for the week is 8.98%, and for the month is 13.70%. The stock’s price to book ratio is 0.21, however price to sale ratio is 0.05. Analyst’s mean recommendation regarding this stock is 2.80. (where 1=Buy, 5=Sale).
Paragon Offshore plc, together with its auxiliaries, provides offshore drilling rigs. The corporation is involved in contracting its rigs, related equipment, and work crews to conduct oil and gas drilling and workover operations for its exploration and production customers on a day rate basis. Its drilling fleet comprises of 34 jackups and 6 floaters, counting 4 drillships and 2 semisubmersibles.
Intrexon Corporation (NYSE:XON)
Intrexon Corporation (XON), declared that Intrexon has signed a Cooperative Research and Development Contract (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health, for the development of adoptive T cell therapies utilizing the RheoSwitch Therapeutic System® (RTS®) platform for the treatment of solid tumor malignancies. The principal aim of the CRADA is to develop and evaluate improved adoptive cell transfer-based immunotherapies (ACT) using NCI proprietary methods for the identification of autologous peripheral blood lymphocytes (PBL) possessing naturally occurring anti-tumor activity combined with Intrexon’s RTS® gene switch for introducing spatially and temporally controlled interleukin-12 (IL-12) expression.
Intrexon Corporation, a biotechnology corporation, operates in the synthetic biology field in the United States. The corporation, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
